FDA Approves Medtronic's Pipeline Flex Aneurysm Device

Saturday, February 7, 2015

Source: Mass Device

Medtronic (NYSE:MDT) said today that the FDA approved the Pipeline Flex embolization device it acquired along with Covidien last month, revealing plans for a limited U.S. release of the brain aneurysm treatment.

The latest iteration of the Pipeline device is designed to treat large and giant aneurysms by preventing blood from flowing into them, according to a press release.

View All News »